نمایش مختصر رکورد

dc.contributor.authorMahin Samadi, Pariyaen_US
dc.contributor.authorGerami, Parmidaen_US
dc.contributor.authorElmi, Alien_US
dc.contributor.authorkhanaki, koroshen_US
dc.contributor.authorFaezi, Sobhanen_US
dc.date.accessioned1399-07-09T08:20:49Zfa_IR
dc.date.accessioned2020-09-30T08:20:50Z
dc.date.available1399-07-09T08:20:49Zfa_IR
dc.date.available2020-09-30T08:20:50Z
dc.date.issued2019-01-01en_US
dc.date.issued1397-10-11fa_IR
dc.date.submitted2018-05-10en_US
dc.date.submitted1397-02-20fa_IR
dc.identifier.citationMahin Samadi, Pariya, Gerami, Parmida, Elmi, Ali, khanaki, korosh, Faezi, Sobhan. (2019). <i>Pseudomonas aeruginosa</i> keratitis: passive immunotherapy with antibodies raised against divalent flagellin. Iranian Journal of Basic Medical Sciences, 22(1), 58-64. doi: 10.22038/ijbms.2018.31499.7643en_US
dc.identifier.issn2008-3866
dc.identifier.issn2008-3874
dc.identifier.urihttps://dx.doi.org/10.22038/ijbms.2018.31499.7643
dc.identifier.urihttp://ijbms.mums.ac.ir/article_11739.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/339697
dc.description.abstract<em><strong>Objective(s):</strong></em> Pseudomonas aeruginosa infections such as keratitis are considered among the major health problems worldwide due to the complexity of pathogenesis and antibiotic resistance crisis, thus, finding new effective approaches for prevention and treatment of the infections seem to be still vital. In this report, we aimed to investigate the therapeutic effects of topical administration of the antibodies against type a and b-flagellin (FLA and FLB) in Pseudomonas keratitis model of infection in mice. <br /><em><strong>Materials and Methods:</strong></em> Scratched corneas of mice were treated with approximately 107 CFUs/eye of PAK and/or PAO1 strains of P. aeruginosa. Specific IgG to FLA, FLB or divalent flagellin were topically applied to the infected corneas for 20 min, 24, and 36 hr post-infection. The bacterial burden and myeloperoxidase activity (as a marker for polymorphonuclears (PMNs) infiltration) were determined in the corneas. The biological activity of the anti-FLA and FLB IgG was evaluated in vitro by opsonophagocytosis test. <br /><strong><em>Results:</em> </strong>Compared to other treated corneas, divalent anti-flagellin IgG treatment showed a significant decrease in the bacterial CFUs and myeloperoxidase activity in the infected corneas (<em>P<</em>0.05). Results of opsonophagocytosis revealed that the specific antibodies raised against FLA and FLB had more potent opsonic killing activity on their homologous strains as compared with control group (<em>P<</em>0.05).<br /> <em><strong>Conclusion:</strong> </em>It appears that in P. aeruginosa keratitis, topical administration of the combined antibodies likely via decreasing the bacterial load, and PMNs infiltration as well as increasing opsonophagocytosis could lead to dramatic improvement of the infected corneas.en_US
dc.format.extent796
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherMashhad University of Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Basic Medical Sciencesen_US
dc.relation.isversionofhttps://dx.doi.org/10.22038/ijbms.2018.31499.7643
dc.subjectDivalent antibodyen_US
dc.subjectFlagellinen_US
dc.subjectKeratitisen_US
dc.subjectMmiceen_US
dc.subject<i>Pseudomonas aeruginosa</i>en_US
dc.subjectMicrobiologyen_US
dc.title<i>Pseudomonas aeruginosa</i> keratitis: passive immunotherapy with antibodies raised against divalent flagellinen_US
dc.typeTexten_US
dc.typeOriginal Articleen_US
dc.contributor.departmentDepartment of Microbiology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iranen_US
dc.contributor.departmentDepartment of Microbiology, Biology Research Center, Zanjan Branch, Islamic Azad University, Zanjan, Iranen_US
dc.contributor.departmentMedical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iranen_US
dc.contributor.departmentMedical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iranen_US
dc.contributor.departmentMedical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iranen_US
dc.citation.volume22
dc.citation.issue1
dc.citation.spage58
dc.citation.epage64
nlai.contributor.orcid0000-0002-4611-9985


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد